14-3-3 Proteins, particularly of the epsilon isoform, are detectable in cerebrospinal fluids of cerebellar diseases in children

Brain and Development

Volumn 35, Issue 6, 2013, Pages 555-560

  Fujii, Katsunori ^a   Uchikawa, Hideki ^a   Tanabe, Yuzo ^b   Omata, Taku ^b   Nonaka, Ikuya ^c   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA CHILDREN'S HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

14 3 3 Protein; Biomarker; Cerebellar disease; Cerebellar disruption; Cerebrospinal fluid (CSF)

Indexed keywords

PROTEIN 14 3 3;

ANTIBODY SPECIFICITY; ARTICLE; BRAIN DISEASE; CEREBELLAR ATAXIA; CEREBELLITIS; CEREBELLUM ATROPHY; CEREBELLUM DISEASE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FEBRILE CONVULSION; FEMALE; HUMAN; IMMUNOBLOTTING; INFLUENZA RELATED ENCEPHALOPATHY; LONGITUDINAL STUDY; MALE; NEUROAXONAL DYSTROPHY; PRESCHOOL CHILD; SCHOOL CHILD;

14-3-3 PROTEINS; CEREBELLAR DISEASES; CEREBELLUM; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA, HUMAN; MAGNETIC RESONANCE IMAGING; MALE; PROTEIN ISOFORMS;

EID: 84876810817     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2012.09.007     Document Type: Article

References (27)

1. Deisenhammer F., Bartos A., Egg R., Gilhus N.E., Giovannoni G., Rauer S., et al. Guideline on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 2006, 13:913-922.
2. Brettschneider J., Petzold A., Süssmuth S., Tumani H. Cerebrospinal fluid biomarkers in Guillain-Barré syndrome - where do we stand?. J Neurol 2009, 256:3-12.
3. Deisenhammer F., Egg R., Giovannoni G., Hemmer B., Petzold A., Sellebjerg F., et al. EFNS guidelines on disease-specific CSF investigations. Eur J Neurol 2009, 16:760-770.
4. Berg D., Holzmann C., Riess O. 14-3-3 Proteins in the nervous system. Nat Rev Neurosci 2003, 4:752-762.
5. Fu H., Subramanian R.R., Masters S.C. 14-3-3 Proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000, 40:617-647.
6. Hsich G., Kenney K., Gibbs C.J., Lee K.H., Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996, 335:924-930.
7. Zeilder M., Gibbs C.J., Meslin F. WHO Manual for Strengthening Diagnosis and Surveillance of Creutzfeldt-Jakob disease 1998, WHO, Geneva.
8. Chohan G., Pennington C., Mackenzie J.M., Andrews M., Everington D., Will R.G., et al. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 2010, 81:1243-1248.
9. Fujii K., Tanabe Y., Uchikawa H., Kobayashi K., Kubota H., Takanashi J., et al. 14-3-3 Protein detection in the cerebrospinal fluid of patients with influenza-associated encephalopathy. J Child Neurol 2006, 21:562-565.
10. Fujii K., Tanabe Y., Kobayashi K., Uchikawa H., Kohno Y. Detection of 14-3-3 protein in the cerebrospinal fluid in mitochondrial encephalopathy with lactic acidosis and stroke-like episodes. J Neurol Sci 2005, 239:115-118.
11. Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol 2010, 9:94-104.
12. Klockgether T., Schroth G., Diener H.C., Dichgans J. Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J Neurol Neurosurg Psychiatry 1990, 53:297-305.
13. Tanabe Y., Iai M., Ishii M., Tamai K., Maemoto T., Ooe K., et al. The use of magnetic resonance imaging in diagnosing infantile neuroaxonal dystrophy. Neurology 1993, 43:110-113.
14. Péterfy M., Harris T.E., Fujita N., Reue K. Insulin-stimulated interaction with 14-3-3 promotes cytoplasmic localization of lipin-1 in adipocytes. J Biol Chem 2010, 285:3857-3864.
15. Xu G., Paige J.S., Jaffrey S.R. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat Biotechnol 2010, 28:868-873.
16. Wakabayashi H., Yano M., Tachikawa N., Oka S., Maeda M., Kido H. Increased concentrations of 14-3-3 epsilon, gamma and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction. Clin Chim Acta 2001, 312:97-105.
17. Shiga Y., Wakabayashi H., Miyazawa K., Kido H., Itoyama Y. 14-3-3 Protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages. J Clin Neurosci 2006, 13:661-665.
18. Boston P.F., Jackson P., Thompson R.J. Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem 1982, 38:1475-1482.
19. Wiltfang J., Otto M., Baxter H.C., Bodemer M., Steinacker P., Bahn E., et al. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 1999, 73:2485-2490.
20. Takahashi H., Iwata T., Kitagawa Y., Takahashi R.H., Sato Y., Wakabayashi H., et al. Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease. Clin Diagn Lab Immunol 1999, 6:983-985.
21. Baxter H.C., Liu W.G., Forster J.L., Aitken A., Fraser J.R. Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 2002, 109:5-14.
22. Umahara T., Uchihara T., Nakamura A., Iwamoto T. Isoform-dependent immunolocalization of 14-3-3 proteins in developing rat cerebellum. Brain Res 2009, 1253:15-26.
23. Umahara T., Uchihara T., Yagishita S., Nakamura A., Tsuchiya K., Iwamoto T. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1. Neurosci Lett 2007, 414:130-135.
24. Bersano A., Fiorini M., Allaria S., Zanusso G., Fasoli E., Gelati M., et al. Detection of CSF 14-3-3 protein in Guillain-Barre syndrome. Neurology 2006, 67:2211-2216.
25. Toyo-oka K., Shionoya A., Gambello M.J., Cardoso C., Leventer R., Ward H.L., et al. 14-3-3 Epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet 2003, 34:274-285.
26. Satoh J., Yamamura T., Arima K. The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. Am J Pathol 2004, 165:577-592.
27. Umahara T., Uchihara T. 14-3-3 Proteins and spinocerebellar ataxia type 1: from molecular interaction to human neuropathology. Cerebellum 2010, 9:183-189.